4 Results for "

PI3K-IN-12

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "PI3K-IN-12" in MCE Product Catalog:

Cat. No.: HY-136806
CAS No.: 1807551-44-5
Target:  

PI3K

Research Areas:  

Cancer

PI3K-IN-12 (comp 76) is a PI3K inhibitor .
loading...
    loading...
Cat. No.: HY-149427
CAS No.: 2966861-50-5
Target:  

PI3K

Research Areas:  

Cancer

PI3Kα-IN-12 (compound 13) is a highly selective PI3Kα inhibitor (IC50: 1.2 nM). PI3Kα-IN-12 inhibits HCT-116 and U87-MG with IC50s values of 0.83 and 1.25 μM, respectively. PI3Kα-IN-12 (40 mg/kg; IP) causes tumor regression in a U87-MG cell line xenograft mouse model .
loading...
    loading...
Cat. No.: HY-149235
Target:  

PI3K

Research Areas:  

Inflammation/Immunology

PI3Kδ-IN-12 (compound 13) is a PI3Kδ inhibitor (pIC50 = 5.8), with pKi values of 8.0/6.5/6.4/6.7 for PI3Kδ/γ/β/α, respectively. PI3Kδ-IN-12 can be used in the study of chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) .
loading...
    loading...
Cat. No.: HY-178485
Research Areas:  

Cancer

SJY26 is a PI3K/HDAC dual-target inhibitor with IC50s of 0.59 nM (PI3Kα and PI3Kδ), 2.02 nM (PI3Kγ), 12.69 nM (PI3Kβ) and 114 nM (HDAC1). SJY26 exhibits potent broad-spectrum anti-proliferative activity, and is particularly sensitive to Jurkat and PC9R cells. SJY26 inhibited the migration of PC9R cells, arrested the cell cycle and induced cell apoptosis. SJY26 reduces AKT phosphorylation, and decreases histone H3 deacetylation (Ac-H3). SJY26 can be used for the studies of non-small cell lung cancer and leukemia .
loading...
    loading...